Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

777
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
777
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

582
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
582
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

804
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
804
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

334
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
334
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

598
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
598
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

446
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
446

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

UNICORN TAVR in Native Complex Congenital Aortic Stenosis at High Risk of Coronary Obstruction.

JACC. Case reports·2026
Same author

Infective Endocarditis Risk After Invasive Dental Procedures.

Mayo Clinic proceedings. Innovations, quality & outcomes·2025
Same author

[2025 ESC/EACTS Guidelines for the management of valvular heart disease].

Giornale italiano di cardiologia (2006)·2025
Same author

Dedicated Versus Conventional Devices in Patients With Pure Native Aortic Regurgitation: A Systematic Review and Meta-Analysis.

Journal of the American Heart Association·2025
Same author

Endocarditis Prophylaxis-Indications, Application and Current Controversies.

The Canadian journal of cardiology·2025
Same author

Aortic Valve Replacement in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Apr 4, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K

感染症性内臓炎

Thomas J Cahill1, Bernard D Prendergast2

  • 1Department of Cardiology, Oxford University Hospitals, Oxford, UK.

Lancet (London, England)
|September 6, 2015
PubMed
まとめ
この要約は機械生成です。

感染症性内心炎は,原因が変化し,高齢の患者に重篤な心臓弁の感染です. 進歩にもかかわらず,死亡率は依然として高く,より良い管理戦略の必要性を強調しています.

さらに関連する動画

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K
Isolation of Valvular Endothelial Cells
11:04

Isolation of Valvular Endothelial Cells

Published on: December 29, 2010

21.1K

関連する実験動画

Last Updated: Apr 4, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K
Isolation of Valvular Endothelial Cells
11:04

Isolation of Valvular Endothelial Cells

Published on: December 29, 2010

21.1K

科学分野:

  • 心臓病科
  • 感染症
  • 臨床医学

背景:

  • 感染症性内心炎 (IE) は,心臓弁と心臓器具に影響を与える世界的な疾患です.
  • 流行病学では 患者の年齢と感染率が 増加していることが示されています
  • マイクロバイオロジーは変化し ステロコックは ストレプトコクシよりも一般的です

研究 の 目的:

  • 感染症性心内炎の現在の臨床実務をレビューする.
  • この病気の管理のための未解決の論争と新興戦略を議論する.
  • 伝染性心内炎の高い死亡率を強調するためです

主な方法:

  • 感染症性心内炎に関する最近の文献のレビュー.
  • 疫学的および微生物学的傾向の分析
  • 診断と治療の進歩についての議論
  • 臨床管理の課題と論争の検討

主要な成果:

  • 患者の平均年齢は2倍になり,心臓器具を装着した患者の発症率は増加しました.
  • 感染性心臓内炎の主な原因として ステロコックは ストレプトコックスを取って代わっています
  • 1年間の死亡率は30%で,新しい診断と治療方法にもかかわらず高いままです.

結論:

  • 感染症性内臓炎は,流行病学と微生物学の分野で進化する課題を提示しています.
  • 高い死亡率は維持されていて,改善された管理戦略の必要性を強調しています.
  • 患者の治療成果を向上させるには 物流上の障壁や論争を 解決することが重要です